(Q43101272)

13 November 2017

In Vitro Evaluation of Oxoplatin: An Oral Platinum(IV) Anticancer Agent (English)

1 reference

13 November 2017

1 reference

5

1 reference

13 November 2017

6

Patrick Bednarski

1 reference

13 November 2017

Ulrike Olszewski

1

1 reference

13 November 2017

Florian Ach

2

1 reference

13 November 2017

Ernst Ulsperger

3

1 reference

13 November 2017

Gerhard Baumgartner

4

1 reference

13 November 2017

Gerhard Hamilton

7

1 reference

13 November 2017

30 June 2009

1 reference

13 November 2017

1 reference

13 November 2017

2009

1 reference

13 November 2017

348916

1 reference

Creative Commons Attribution 3.0 Unported

13 November 2017

start time

30 June 2009

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Current status and future prospects for satraplatin, an oral platinum analogue

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705772

Platinum complexes as anticancer agents

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705772

The resurgence of platinum-based cancer chemotherapy

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705772

Basis for design and development of platinum(IV) anticancer complexes

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705772

Broadening the clinical use of platinum drug-based chemotherapy with new analogues. Satraplatin and picoplatin

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705772

Photoactivatable platinum complexes

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705772

Molecular mechanisms of resistance and toxicity associated with platinating agents

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705772

Preclinical perspectives on the use of platinum compounds in cancer chemotherapy

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705772

The mechanism of action of platinum(IV) complexes in ovarian cancer cell lines

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705772

Cisplatin and platinum drugs at the molecular level. (Review)

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705772

INHIBITION OF CELL DIVISION IN ESCHERICHIA COLI BY ELECTROLYSIS PRODUCTS FROM A PLATINUM ELECTRODE

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705772

Interaction of cisplatin with human serum albumin. Drug binding mode and protein secondary structure

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705772

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705772

Cellular responses to cisplatin. The roles of DNA-binding proteins and DNA repair

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705772

New platinum agents. A comparison in ovarian cancer

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705772

New cisplatin analogues in development. A review

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705772

Pharmacokinetic research on oxoplatinum

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705772

Glutathione-mediated activation of anticancer platinum(IV) complexes

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705772

Identification of cis-dichloro-bis-isopropylamine platinum(II) as a major metabolite of iproplatin in humans

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705772

Isolation of cDNAs encoding a human protein that binds selectively to DNA modified by the anticancer drug cis-diamminedichloroplatinum(II)

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705772

The antitumor activity of oxoplatinum.

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705772

Synthesis and in vitro antitumoral activity of novel O,O'-di-2-alkyl-(S,S)-ethylenediamine-N,N'-di-2-propanoate ligands and corresponding platinum(II/IV) complexes.

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705772

Studies of the binding of a series of platinum(IV) complexes to plasma proteins

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2705772

Purification of nuclear proteins that bind to cisplatin-damaged DNA. Identity with high mobility group proteins 1 and 2

15 August 2018

1 reference

12 December 2020

Synthesis, physical properties, and antitumor activity of tetraplatin and related tetrachloroplatinum(IV) stereoisomers of 1,2-diaminocyclohexane

1 reference

12 December 2020

Modifying the properties of platinum (IV) complexes in order to increase biological effectiveness

1 reference

12 December 2020

DNA interactions of bifunctional dinuclear platinum(II) antitumor agents

1 reference

12 December 2020

cis-Diamminedichloroplatinum(II) selectively cross-links high mobility group proteins 1 and 2 to DNA in micrococcal nuclease accessible regions of chromatin

1 reference

12 December 2020

Effect of oxoplatinum and CBDCA on renal functions in rats

1 reference

12 December 2020

Interaction of the antitumor agents cis,cis,trans-PtIV(NH3)2Cl2(OH)2 and cis,cis,trans-PtIV[(CH3)2CHNH2]2Cl2(OH)2 and their reduction products with PM2 DNA

1 reference

12 December 2020

Antitumor effect of complex compounds of tetravalent platinum

1 reference

12 December 2020

The fate of platinum(II) and platinum(IV) anti-cancer agents in cancer cells and tumours

1 reference

12 December 2020

Pharmacokinetics of the antitumor drug oxoplatinum labeled with 191Pt

1 reference

12 December 2020

DNA interactions of antitumor platinum(IV) complexes

1 reference

12 December 2020

Identifiers

DOI

10.1155/2009/348916

1 reference

13 November 2017

1 reference

13 November 2017

PubMed publication ID

19587824

1 reference